GSK-FLTB3054 (FLIT78) [ISOLDE]

Study Sponsor: GSK

Study Title

A multicentre, double-blind, placebo-controlled, parallel group study of the efficacy and tolerability of long-term inhaled fluticasone propionate 500mg twice daily via a Volumatic Spacer device in patients with non-asthmatic chronic obstructive pulmonary disease, including…

Medicine or Vaccine (generic name)

fluticasone propionate

Sponsor Identification Number

FLTB3054 (FLIT78) [ISOLDE]

Trial Registry Identification Number(#'s)

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=FLTB3054

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.

Date Added to this Site

May 2014